Home › Studies › PRJEB10391
PRJEB10391 ERP011645

Ciprofloxacin impact on gut resistome in healthy adults

Impact of ciprofloxacin pertubation on the intestinal resistome and microbiota in two healthy volunteers

12 stool samples from two healthy adult male volunteers in Germany, collected before, during and after a 6-day course of oral ciprofloxacin, to study effects on intestinal antibiotic resistance genes. machine-written summary

12 samples · 12 runs · DE · Adult · 2015 · 6.62 Gbp / sample

Sources
✓Sequence archive 112✓Abstract / description 4○Full text○Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive112 sample values (antibiotic exposure, collection date, country, intervention, latitude, location region, longitude, sex)
✓ Abstract / description4 sample values (antibiotic exposure)
○ Full textread; no usable statement or table · PMC4649198, PMC8288446
○ Supplementary tablesfiles read; no table could be matched to the samples
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Interventions

intervention — arms not resolved

Antibiotic given as the study intervention (incl. eradication therapy design single_arm_before_after · population healthy_control · Ciprofloxacin 500 mg orally twice daily for 6 days

“treated with ciprofloxacin for 6 days” — bioproject.description (study level; per-sample arms are in the intervention column below)

Samples at a glance
1 sampling locations · 1 country
Age
adult12
Sex
male12
Country
DE12
Body site
primary12
Collected 2013–2014
2013: 10 samples2014: 2 samples20132014
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)all projects, 1–3 Gbp: 124,983 samples (22 %)all projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 12 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)all projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 6.62 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinal

2 of 2 people sampled more than once (12 samples; median 6, up to 6 per person) · follow-up median 31 d (max 31 d) · median interval between samples 31 d (time from collection months (month precision)). Schedule stated by the source: “Stool collected before treatment (baseline), on days 1, 3, 6 of ciprofloxacin treatment, and 2 and 28 days after treatment ended.” (time origin: intervention start); stated follow-up 28 d.

TUE-S1TUE-S1: day 0TUE-S1: day 0TUE-S1: day 0TUE-S1: day 0TUE-S1: day 0TUE-S1: day 31TUE-S2TUE-S2: day 0TUE-S2: day 0TUE-S2: day 0TUE-S2: day 0TUE-S2: day 0TUE-S2: day 310 d8 d16 d23 d31 d

Each row is one person (2 shown); dots are samples at days since that person's first sample.

How longitudinal and relatedness information is derived

Community composition
Phocaeicola 27.4%Bacteroides 25.8%Alistipes 10.7%Roseburia 4.5%Coprobacter 4.1%Faecalibacterium 2.1%Acetatifactor 1.4%Akkermansia 1.4%Sutterella 1.3%Gemmiger 1.2%Barnesiella 1.1%Parabacteroides 1.1%not assigned to a genus 2.9%other genera 15.1%

Genera, mean relative abundance over 8 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category12 100%
country12 100%12
health_condition0 0%
subject_id12 100%12
antibiotic_exposure12 100%84
collection_date12 100%12
detailed_location12 100%
latitude12 100%12
location_region12 100%12
longitude12 100%12
sex12 100%12
timepoint_label12 100%12
intervention8 67%8
Papers (2)
  • Antibiotic Selection Pressure Determination through Sequence-Based Metagenomics. 2015 PMID 26369961 PMC4649198 own_data
  • Dispersal strategies shape persistence and evolution of human gut bacteria. 2021 PMID 34111423 PMC8288446 unsure
Details
Archive description

Two healthy male volunteers (S1 and S2) were treated with ciprofloxacin for 6 days (500 mg orally twice daily). Stool samples from both participants were collected before treatment (baseline), on day 1, 3 and 6 of treatment as well as 2 and 28 days after treatment. Metagenomic shotgun sequencing was performed with all samples.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of adult by deterministic_prior with confidence 0.90. Assay shotgun_dna.

  • host external_curation.infant_catalog · “infant triage reason_code age_unknown_no_evidence”
  • body site study.title · “pertubation on the intestinal resistome and microbiota”
  • body site study.description · “orally twice daily). Stool samples from both”
  • life stage study.title · “in two healthy volunteers”
  • life stage study.description · “Two healthy male volunteers (S1 and S2)”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMEA3506758antibiotic_exposurenoR10.85biosample.attribute:descriptionbaseline stool sample
SAMEA3506762antibiotic_exposureyesR40.50study.descriptiontreated with ciprofloxacin for 6 days
SAMEA3506758collection_date2013-12R10.90biosample.attribute:collection_date2013-12
SAMEA3506758countryDER10.90sample.attr.geographic_location_country_and_or_seaGermany
SAMEA3506758interventionno_interventionR10.85biosample.attribute:descriptionbaseline stool sample
SAMEA3506758latitude48.5369R10.90biosample.attribute:geographic_location_latitude+geographic_location_longitude48.5369 9.0536
SAMEA3506758location_regionBaden-WuerttembergR10.60biosample.attribute:geographic_location_latitude+geographic_location_longitude48.5369 9.0536
SAMEA3506758longitude9.0536R10.90biosample.attribute:geographic_location_latitude+geographic_location_longitude48.5369 9.0536
SAMEA3506758sexmaleR10.90sample.attr.host_sexmale
SAMEA3506758subject_idTUE-S1R10.70sample.name_rule:aliasTUE-S1_1
SAMEA3506758timepoint_labelbaseline stool sampleR10.85biosample.attribute:descriptionbaseline stool sample
Sequencing

12 runs over 12 samples · mean 6.89 Gbp per run (median 6.62 Gbp, total 82.71 Gbp; 12 runs with a base count) · layout PAIRED 12 · platform ILLUMINA 12 · models Illumina HiSeq 2000 (12) · 67% of runs with a Sandpiper profile · first public 2015-09-07

Authors (17)

Willmann M first · El-Hadidi M · Huson DH · Schütz M · Weidenmaier C · Autenrieth IB · Peter S last · Hildebrand F first · Gossmann TI · Frioux C · Özkurt E · Myers PN · Ferretti P · Kuhn M · Bahram M · Nielsen HB · Bork P last

Downloads

PRJEB10391.csv.gz (1.3 KB) · parquet (70.9 KB) — all 12 samples, every field with route and confidence · PRJEB10391_determinations.csv.gz (1.7 KB) — 116 evidence rows

Samples (12 · every field this project has values for · hover a cell for its source)
Loading the sample table…